Won-Jin Moon1
1Konkuk University Medical Center, Korea, Republic of
Synopsis
Keywords: Image acquisition: Quantification, Contrast mechanisms: Perfusion, Education Committee: Clinical MRI
In this lecture, we will dive into the clinical applications of MR perfusion quantification, encompassing both neuroimaging and body imaging. The focus will be on dynamic susceptibility contrast (DSC) imaging and dynamic contrast-enhanced (DCE) imaging techniques, highlighting their pivotal roles in improving patient diagnosis, treatment planning, and outcome prediction. Participants will gain insights into the versatile applications and inherent advantages of MR perfusion in clinical practice, enabling them to leverage this powerful tool for enhanced patient care.
Perfusion
MR imaging has emerged as a powerful tool in clinical medicine, offering a
non-invasive window into tissue perfusion, the rate of blood flow through
organs and tissues. This lecture delves into the clinical applications of
perfusion MRI techniques, focusing on how they provide valuable quantitative
data for disease diagnosis, treatment planning, and monitoring.
While
the prior lecture addressed the technical aspects of perfusion MRI, this
session emphasizes its clinical utility. We'll explore two main techniques:
Dynamic Susceptibility Contrast (DSC) imaging and Dynamic Contrast Enhanced
(DCE) imaging. Each technique offers distinct advantages and limitations, but
all share the ability to quantify blood flow parameters.
Quantitative perfusion MRI plays a vital role in various
clinical settings. In stroke evaluation, it helps identify areas with reduced
blood flow (ischemia) and potentially salvageable tissue for treatment
decisions. Brain tumor characterization benefits from perfusion data, aiding in
differentiating tumor types and assessing their aggressiveness. Perfusion MRI
can also be used to investigate blood flow/permeability associated with
Alzheimer's disease and other neurodegenerative diseases.
Perfusion MRI's quantitative capabilities extend beyond
neurology. In cardiac MRI, it measures myocardial blood flow and perfusion
reserve, aiding in the diagnosis of coronary artery disease. Renal MRI utilizes
perfusion to assess kidney function by quantifying renal blood flow. Perfusion
MRI also finds applications in oncology, where tracking changes in perfusion
parameters helps monitor tumor response to treatment.
The field of
quantitative perfusion MRI is constantly evolving. Researchers are developing
improved data acquisition techniques to minimize artifacts and enhance data
quality. Robust quantification methods are being established to ensure reliable
and accurate parameter measurement. Machine learning algorithms are making
significant strides in automating analysis, saving time, and potentially
improving accuracy. Additionally, standardization efforts are underway to
facilitate wider clinical adoption of quantitative perfusion MRI across
different institutions and scanners.
In
conclusion, perfusion MRI has emerged as a powerful tool for clinical
diagnosis, treatment planning, and monitoring disease progression. Its ability
to quantify blood flow parameters offers valuable insights into various disease
processes, paving the way for a more personalized approach to patient care.Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIP) (grant number 2020R1A2C1102896) and the Korea Health Technology R&D Project through the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HU21C0222).References
1. Demeestere, J., Wouters, A., Christensen, S., Lemmens, R. & Lansberg, M. G. Review of Perfusion Imaging in Acute Ischemic Stroke. Stroke 51, 1017–1024 (2020).
2. Sarraj, A., Pujara, D. K. & Campbell, B. C. Current State of Evidence for Neuroimaging Paradigms in Management of Acute Ischemic Stroke. Ann. Neurol. (2024)
3. Dijken, B. R. J. van et al. Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques. J. Magn. Reson. Imaging 49, 11–22 (2019).
4. Lee, J. et al. MR Perfusion Imaging for Gliomas. Magn. Reson. Imaging Clin. North Am. 32, 73–83 (2024).
5. Moon, W.-J. et al. Hippocampal blood–brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia. J Cereb Blood Flow Metabolism 41, 1351–1361 (2020).
6. Choi, J. D. et al. Choroid Plexus Volume and Permeability at Brain MRI within the Alzheimer Disease Clinical Spectrum. Radiology 304, 635–645 (2022).
7. Patel, A. R. & Kramer, C. M. Perfusion Imaging for the Heart. Magn. Reson. Imaging Clin. North Am. 32, 125–134 (2024).
8. Wu, M. & Zhang, J. L. MR Perfusion Imaging for Kidney Disease. Magn. Reson. Imaging Clin. North Am. 32, 161–170 (2024).
9. Oh, G., Moon, Y., Moon, W.-J. & Ye, J. C. Unpaired deep learning for pharmacokinetic parameter estimation from dynamic contrast-enhanced MRI without AIF measurements. NeuroImage 291, 120571 (2024).
10. Yu, Y. et al. Predicting Hypoperfusion Lesion and Target Mismatch in Stroke from Diffusion-weighted MRI Using Deep Learning. Radiology 307, e220882 (2023).